Obtain mechanistic understanding and novel insights into disease biology.

Speed up

Speed up your early R&D process and reduce your time to decision making.


Identify targets and lead compounds with potential to produce first-in-class medicines.
Our services

An approach you can trust

We are seasoned specialists in providing neurobiology research services. Our mission is to create groundbreaking in vitro concepts that will advance the neuroscience research field and enable our Clients to conduct successful drug discovery programs.
Read more arrow_forward

Basic research

From deciphering disease mechanisms to exploration of novel assay concepts.

Target discovery

Using functional genomics and advanced in vitro models we help our Clients to identify and validate novel targets.

Lead discovery

Phenotypic and target-based assay development, screening and lead optimization.
Our platform

Elevated neurobiology in vitro research

What sets us apart from the competition is our unique discovery platform. By combining drug discovery expertise and disease area knowledge with cutting-edge technologies, we create complex disease models and assays for functional and morphological screening.
Read more arrow_forward

News and events

Latest news and insights

Cellectricon values scientific exchange and we invite you to take part of our latest news and to learn about upcoming events.

Read more

A PhD position in pain research available in collaboration with Karolinska Institutet
We are looking for a new colleague for an open position as PhD fellow in the EU-funded Marie Skłodowska-Curie Actions...
May 27-28, 2024
Neuro4D 2024
The Neuro4D conference takes place in Mainz, Germany on May 27-28, 2024. With a focus on drug discovery for proteopathic...
Cellectricon and Fluicell initate collaboration to validate tissue-based in vitro models
We’re excited to be working with Fluicell AB and support their development of bioprinted tissues for use in research and...
May 22-23, 2024
Discovery Europe
Discovery Europe and the Neuroscience Drug Development Europe meetings take place in parallel in Basel, Switzerland on May 22-23, 2024....
Cellectricon launches Neuroinflammation Research Service
MÖLNDAL, SWEDEN Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, has launched the Neuroinflammation Research Service module. Established...
Dr. Jonathan Levenson joins Cellectricon’s advisory board
Cellectricon has appointed Dr. Jonathan Levenson, Chief Scientific Officer at FireCyte Therapeutics, to its Scientific Advisory Board. Dr. Levenson brings...
Cellectricon’s expertise in pain research recognized by second EU research grant
MÖLNDAL, SWEDEN Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, has received follow-on funding for bone pain research...
New publication: A Microfluidic High-Capacity Screening Platform for Neurological Disorders
We are happy to announce the publication of “A Microfluidic High-Capacity Screening Platform for Neurological Disorders”. In the paper, published...
Cellectricon expands neuroscience contract research portfolio with new Neuroplasticity services
Mölndal, Sweden Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, today announced the launch of a new service...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Social media

Cellectricon on LinkedIn

Follow us on LinkedIn

Webcasts and videos

Check out our YouTube channel to view select webcasts and presentations from our in-house experts and collaborators.

Follow us on YouTube